Unknown

Dataset Information

Antibody therapies for lymphoma in children.


ABSTRACT:

Background

Lymphomas are the third most common malignancy in childhood. Cure rates are high but have reached a plateau. Therefore new treatment modalities should be developed. Antibody therapy is a successful new treatment option in adult lymphoma. However, none of the therapeutic antibodies available for adults with cancer have been approved for treatment of paediatric lymphoma.

Objectives

To assess the efficacy of antibody therapy for childhood lymphoma in terms of survival, response and relapse rates, compared with therapy not including antibody treatment. To assess quality of life and the occurrence of adverse effects caused by antibody therapy treatment in children compared with therapy not including antibody treatment.

Search methods

We searched the Cochrane Cen

SUBMITTER: de Zwart V 

PROVIDER: S-EPMC8719646 | biostudies-literature | 2016 Jan

REPOSITORIES: biostudies-literature